Short answer

Testimonials are personal accounts, not clinical evidence. The FDA has not approved cannabis or cannabis extracts for PTSD. Two FDA-approved cannabinoid drugs, dronabinol and nabilone, are approved for chemotherapy-related nausea, not for PTSD. Nabilone has been tested in small PTSD trials. Results are mixed.

How Medical Cannabis Changed My Life: Patient Bio Guide

What testimonials report

Patient accounts name four symptoms most often.

medical cannabis patient feedback on anxiety

  • Nightmares and broken sleep
  • Intrusive memories
  • Hyperarousal and startle response
  • Avoidance and social withdrawal

Reported effects are shorter time to sleep, fewer remembered nightmares, and lower daytime tension. Onset varies. Some people report a change after one dose. Others report no change.

read more

Products named

Accounts name flower, oils, tinctures, capsules, and edibles. THC and CBD appear in different ratios. Most reports omit THC percentage, CBD percentage, dose in milligrams, and lab source. Without those numbers, one report cannot be compared with another.

related article

What the research shows

The Department of Veterans Affairs states there is not enough evidence to recommend cannabis for PTSD. A 2019 review of cannabinoid trials found low-strength evidence and small samples. Observational studies point in two directions. Some link cannabis use to lower PTSD symptom scores. Others link heavier use to more severe PTSD, more depression, and cannabis use disorder. NIDA reports the same split.

Why a testimonial differs from a trial

  • No placebo group. PTSD symptoms rise and fall on their own.
  • Expectancy. A person who expects relief may report relief.
  • Memory bias. Recall of symptom change is not measured.
  • Self-selection. People who improved are more likely to post.
  • Mixed treatments. Therapy, SSRIs, sleep aids, and exercise often change at the same time.
  • Unverified labels. State-legal products vary in potency and purity.

How to read one report

  1. Find the product, the ratio, and the dose in milligrams.
  2. Find the duration of use.
  3. Find what else changed in the same period.
  4. Find who wrote it and what they sell.
  5. Find a second source that measures the same outcome.

Questions for a clinician

  • Does my PTSD score change if I stop?
  • Does cannabis interact with my antidepressant or sleep aid?
  • What is my risk for cannabis use disorder?
  • Which symptoms am I tracking, and how often?

Cannabis remains a Schedule I controlled substance under federal law. State laws differ. A rescheduling review is in progress. Testimonials can describe an experience. They cannot show cause.